THE ROLE OF NEUROPEPTIDES IN CARDIOVASCULAR REGULATION

被引:20
作者
GANTEN, D
PAUL, M
LANG, RE
机构
[1] German Institute for High Blood Pressure Research and Department of Pharmacology, University of Heidelberg, Heidelberg, D-6900
关键词
PEPTIDES; CARDIOVASCULAR SYSTEM; BLOOD PRESSURE; HEART; ANGIOTENSIN; RENIN; NEUROPEPTIDE-Y; CALCITONIN GENE RELATED PEPTIDE;
D O I
10.1007/BF03029807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the past few years more than 30 novel, biologically active peptides have been discovered. Some are produced in endocrine glands and circulate as hormones in the blood; others are contained in the enterochromaffin cells of the gut and may be involved in the regulation of intestinal functions. The vast majority of new peptides, however, have been detected in the central and peripheral nervous systems, where they are synthesized in distinct neurons and stored in neurovesicles. Many of these neuropeptides may be involved in circulatory regulation. There is evidence supporting such a role, especially for centrally located angiotensin, opioid peptides, substance P, neuropeptide Y (NPY), vasopressin, atrial natriuretic peptide (ANP), kinins, corticotropin releasing factor, bombesin, and somatostatin. In this review we discuss the cardiovascular actions of angiotensin, neuropeptide Y, and calcitonin gene related peptide.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 108 条
[71]  
Kasakov L., Ellis J., Kirkpatrick K., Et al., Direct evidence for concomitant release of noradrenaline, adenosine 5′-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens, J Auton Nerv Sys, 22, pp. 75-82, (1988)
[72]  
Lundberg J.M., Rudehill J.M., Sollevi A., Et al., Frequency-and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen, Neurosci Lett, 36, pp. 96-100, (1986)
[73]  
Lundberg J.M., Torssell L., Sollevi A., Et al., Neuropeptide Y and sympathetic vascular control in man, Regul Pept, 13, pp. 41-52, (1985)
[74]  
Zukowska-Grojec Z., Marks E.S., Haass M., Neuropeptide Y is a potent vasoconstrictor and a cardiodepressent in rat, Am J Physiol, 253, pp. H1234-H1239, (1987)
[75]  
Lundberg J.M., Tatemoto K., Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to α-adrenoceptor-resistant sympathetic vasoconstriction, Acta Physiol Scand, 116, pp. 393-402, (1982)
[76]  
Adrian T.E., Terenghi G., Brown M.J., Et al., Neuropeptide Y in pheochromocytomas and ganglioneuroblastomas, Lancet, 2, pp. 540-543, (1983)
[77]  
Ekblad E., Edvinsson L., Wahlestedt C., Et al., Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers, Regul Pept, 8, pp. 225-235, (1984)
[78]  
Edvinsson L., Ekblad E., Hakanson R., Wahlestedt C., Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels, Br J Pharmacol, 83, pp. 519-525, (1984)
[79]  
Pernow J., Saria A., Lundberg J.M., Mechanisms underlying pre-and post junctional effects of neuropeptide Y in sympathetic vascular control, Acta Physiol Scand, 126, pp. 239-249, (1986)
[80]  
Pernow J., Ohlen A., Hokfelt T., Et al., Neuropeptide Y: Presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man, Regul Pept, 19, pp. 313-324, (1987)